Prevalence and profile of EGFR mutations in NSCLC: Insights from an Eastern Indian cohort
Lung cancer is the leading cause of cancer-related mortality globally. In recent years, molecular targeted therapies particularly those aimed at epidermal growth factor receptor (EGFR) mutations have improved clinical outcomes in non-small cell lung carcinoma (NSCLC). Despite these advances, the overall disease bur...